Downward delegation of implantable cadioverter defibrillator decision-making in a restricted-resource environment: The pitfalls of bedside rationing

Canadian Journal of Cardiology

Volumn 21, Issue 7, 2005, Pages 595-599

  Simpson, Christopher S ^a,d   Hoffmaster, Barry ^b   Dorian, Paul ^c  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

Ethics; Health care resources; Implantable cardioverter defibrillators; Public policy; Rationing

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METOPROLOL; SIMVASTATIN;

ARTICLE; BLOOD CLOT LYSIS; CANADA; CLINICAL TRIAL; DEFIBRILLATOR; HEALTH CARE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEART FAILURE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL DECISION MAKING; MEDICAL ETHICS; MORTALITY; PATIENT CARE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; RESOURCE ALLOCATION; SUDDEN DEATH;

CANADA; COST SAVINGS; DECISION MAKING; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEALTH CARE RATIONING; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALE; NATIONAL HEALTH PROGRAMS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; POINT-OF-CARE SYSTEMS; POLICY MAKING; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TACHYCARDIA, VENTRICULAR;

EID: 21644476456     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Connolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 2000;21:2071-8.
2. Lee DS, Green LD, Liu PF, et al. Effectiveness of implantable defibrillators for preventing arrhythmic events and death: A meta-analysis. J Am Coll Cardiol 2003;41:1573-82.
3. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
4. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997;337:15 76-83.
5. Moss AJ, Hall WJ, Cannom DS, et al; Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-40.
6. Moss AJ, Zareba W, Hall WJ, et al; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
7. Pfeffer MA, Braunwald E, Moye LA, et al; The SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 1992;327:669-77.
8. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
9. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. J Am Coll Cardiol 1988;12(6 Suppl A):3A-13A.
10. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-7.
11. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
12. Blue Cross and Blue Shield Association. Special Report: Cost-Effectiveness of Implantable Cardioverter-Defibrillators in a MADIT-II Population. Assessment Program 2004;19:1-26. http://www.bcbs.com/tec/Vol19/19_03.pdf (Version current at May 9, 2005).
13. Duke University Medical Center, "Implantable Defibrillators Cost-Effective For Many Heart Failure Patients", news release, November 10, 2004. http://www.dukehealth.org/HealthPortals/heart/news /8273 (Version current at March 2, 2005).
14. Irvine J, Dorian P, Baker B, et al. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J 2002;144:282-9.
15. Parkash R, Tang A, Wells G, et al. Use of implantable cardioverter defibrillators after out-of-hospital cardiac arrest: A prospective follow-up study. CMAJ 2004;171:1053-6.
16. Dorian P, Mangat I, Korley V. Do Canadian cardiologists agree with arrhythmia guidelines? Heart Rhythm 2004;1S:S33.
17. Gillis AM. Referring patients for consideration of device treatment of sudden cardiac death and heart failure: Incorporating evidence-based therapies within the Canadian health care system. Can J Cardiol 2005;21(Suppl A):25A-30A.
18. Wilson S, Kadwell S, Kane C, Crysler J. Variations in utilization of implantable cardioverter defibrillators across Canada. Can J Cardiol 2004;20(Suppl D):147D.
19. Hunter DJ. Rationing: The case for "muddling through elegantly". BMJ 1995;311:811.
20. The Ottawa Hospital. Supervisor of The Ottawa Hospital Announces Non-Board Community Representatives For Board Of Governors. News release, September 30, 2002.
21. Ubel PA, Goold SD. 'Rationing' health care. Not all definitions are created equal. Arch Intern Med 1998;158:209-14.
22. Morreim EH. Gaming the system: Dodging the rules, ruling the dodgers. Arch Intern Med 1991;151:443-7.
23. McInerney v. MacDonald, [1992] 2 S.C.R. 138.
24. Norberg v. Wynrib, [1992] 2 S.C.R. 224.
25. Daniels N, Sabin JE. Setting Limits Fairly: Can We Learn to Share Medical Resources? New York: Oxford University Press, 2002.